GlassScriptPhysician profile
George Barnett
NPI 1699969691
$1,032.88
in general payments reported to CMS, 2019-2025
13 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.57 · 2020: $83.31 · 2021: $205 · 2022: $105 · 2023: $117 · 2024: $287 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.40 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $305.37 | 2024-2025 | |
| Abbvie INC. | $212.21 | 2020-2022 | |
| Medical Device Business Services, INC. | $154.88 | 2024 | |
| Coopersurgical, INC. | $62.21 | 2023 | Summit Doppler, Advincula Delineator Uterine Manipulator |
| Daiichi Sankyo INC. | $48.25 | 2021-2022 | |
| Astellas Pharma US INC | $44.56 | 2022-2024 | Veozah |
| Allergan, INC. | $42.33 | 2019-2020 | |
| Baudax Bio INC. | $40.04 | 2022 | |
| Ethicon US, LLC | $37.58 | 2020 | |
| Innovation Technologies INC | $31.01 | 2023 | Irrisept |
| Sumitomo Pharma America, INC. | $23.77 | 2023 | Myfembree |
| Solventum Corporation | $18.90 | 2024 | Prevena |
| Bayer Healthcare Pharmaceuticals INC. | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Barnett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.